Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

IN8bio, Inc.

1.77
+0.05002.91%
Post-market: 1.770.00000.00%17:16 EST
Volume:39.16K
Turnover:68.60K
Market Cap:8.20M
PE:-0.19
High:1.80
Open:1.70
Low:1.70
Close:1.72
52wk High:12.53
52wk Low:1.53
Shares:4.63M
Float Shares:4.28M
Volume Ratio:1.31
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.5432
EPS(LYR):-17.0525
ROE:-189.72%
ROA:-80.39%
PB:0.62
PE(LYR):-0.10

Loading ...

OverviewCompanyNewsFilings

IN8BIO Inc. Announces Promising New Data from INB-200 Clinical Trial, Demonstrating Extended Progression-Free Survival in Glioblastoma Patients

Reuters
·
Aug 08

IN8bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire
·
Aug 08

Top Premarket Decliners

MT Newswires Live
·
Jun 09

IN8BIO Inc. Announces 1-for-30 Reverse Stock Split Effective June 5, 2025

Reuters
·
Jun 04

IN8BIO Inc. Publishes Presentation on Harnessing Gamma-Delta T Cell Therapies for Oncology and Autoimmune Diseases

Reuters
·
Jun 04

IN8BIO Inc. Unveils Presentation on Harnessing the Power of Gamma-Delta T Cells for Cancer Treatment

Reuters
·
Jun 02

BRIEF-In8bio Presents Positive Phase 1 Data Of Inb-200 In Newly Diagnosed Gbm Demonstrating Prolonged Progression-Free Survival

Reuters
·
Jun 02

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Nov 06, 2025 Post Market
Financial Report Announcement
Aug 07, 2025 Post Market
Split&Reverse Split
Jun 06, 2025 30 for 1
Financial Report Announcement
May 07, 2025 Post Market
Financial Report Announcement
Sep 10, 2021

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.19
Current
-6.16
Sector Average
91.04%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.19
Maximum
-0.27
+1 STD
7.64
Minimum
-60.56
-1 STD
-19.95
Average
-6.16

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.